Geron Corp (GERN)
3.81
-0.09
(-2.31%)
USD |
NASDAQ |
May 17, 16:00
3.82
+0.01
(+0.26%)
After-Hours: 20:00
Geron Total Long Term Debt (Quarterly): 82.74M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 82.74M |
December 31, 2023 | 81.94M |
September 30, 2023 | 51.90M |
June 30, 2023 | 51.64M |
March 31, 2023 | 51.40M |
December 31, 2022 | 51.16M |
September 30, 2022 | 50.76M |
June 30, 2022 | 50.42M |
March 31, 2022 | 50.18M |
December 31, 2021 | 49.83M |
September 30, 2021 | 34.67M |
June 30, 2021 | 34.42M |
March 31, 2021 | 24.22M |
December 31, 2020 | 24.04M |
September 30, 2020 | 23.88M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
82.74M
Maximum
Mar 2024
35.66M
Average
42.25M
Median
Total Long Term Debt (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | -- |
SELLAS Life Sciences Group Inc | -- |
Johnson & Johnson | 33.63B |
Pfizer Inc | 68.71B |
Immuneering Corp | -- |